Medical Equipment

Projected Growth of the Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market to Reach $2.29 Billion by 2029

December 8, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the minimally invasive glaucoma surgery (migs) devices market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market By The End Of 2029?

The minimally invasive glaucoma surgery (migs) devices market has experienced rapid expansion in its size over recent years. It is anticipated to grow from $0.7 billion in 2024 to $0.89 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 27.6%. The historical surge can be attributed to several factors including enhanced awareness for the prevention of blindness, greater investments in healthcare infrastructure, heightened patient knowledge about advanced corrective vision treatments, a general increase in awareness surrounding advanced corrective vision treatments, and expanded government initiatives.

The minimally invasive glaucoma surgery (migs) devices market is projected to experience substantial expansion in the coming years. This market is forecast to reach $2.29 billion by 2029, achieving a compound annual growth rate (CAGR) of 26.5%. Several factors are contributing to this growth during the projected period, including the rising incidence of eye conditions such as glaucoma, an expanding elderly demographic, improving healthcare infrastructure, and the increasing demand for safer and more effective treatment options. Key trends anticipated for the forecast period encompass the wider adoption of MIGS devices, ongoing technological advancements, the creation of novel minimally invasive glaucoma surgery devices, the evolution of sophisticated implantable devices, and progress in ophthalmic technology.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp

Which Business Drivers Are Underpinning The Growth Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

The rising occurrence of ocular conditions is projected to drive the expansion of minimally invasive glaucoma surgery (MIGS) devices in the future. These eye conditions cover a broad spectrum of ailments impacting both vision and the eyes themselves. The growing incidence of eye disorders stems from shifts in lifestyle, environmental factors, and an aging demographic. Minimally invasive glaucoma surgery (MIGS) devices represent advanced instruments employed in treating diverse eye ailments, primarily aiming to lower intraocular pressure (IOP) to impede or manage the advancement of glaucoma. For example, as reported by the National Eye Institute, a US-based government agency, in 2024, approximately 2.2 million Americans are anticipated to experience blindness or partial blindness by 2030. Consequently, the escalating incidence of eye conditions fuels the market for minimally invasive glaucoma surgery (MIGS) devices.

What Are The Principal Segment Types In The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

The minimally invasive glaucoma surgery (migs) devicesmarket covered in this report is segmented –

1) By Product: Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents, Other Products

2) By Surgery: Glaucoma In Conjunction With Cataract, Stand Alone Glaucoma

3) By Target: Trabecular Meshwork, Suprachoroidal Space, Other Targets

4) By Distribution Channel: Direct Tender, Retail Sales

5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS), Other End Users

Subsegments:

1) By Valves: Micro Shunt Valves, Non-penetrating Valves

2) By Glaucoma Drainage Implant: Scleral Drainage Implants, Subconjunctival Drainage Implants

3) By Glaucoma Tube Shunts: Ahmed Tube Shunt, Baerveldt Tube Shunt

4) By Stents: Ab-Interno Stents, Ab-Externo Stents

5) By Other Products: Cyclodestructive Devices, Trabecular Bypass Devices

How Are Industry Trends Steering The Expansion Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

Companies at the forefront of the minimally invasive glaucoma surgery (MIGS) devices market are concentrating on developing innovative products, including stent injectable systems, to address unmet needs in glaucoma management and enhance patient outcomes. A stent injectable system functions as a minimally invasive glaucoma surgery (MIGS) device that implants a small stent into the body through an injection-like procedure, frequently employing a specialized delivery mechanism commonly utilized in minimally invasive surgeries for conditions such as blocked or narrowed blood vessels. For instance, in August 2022, Glaukos Corporation, a US-based ophthalmic medical technology company, secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the iStent Infinite Trabecular Micro-Bypass System. The iStent Infinite is a novel three-stent injectable system crafted to offer foundational, 24/7 intraocular pressure (IOP) control for patients with primary open-angle glaucoma (POAG) whose IOP has not been controlled by previous medication and surgical therapy.

Which Companies Are Contributing Significantly To The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Growth?

Major companies operating in the minimally invasive glaucoma surgery (MIGS) devices market are AbbVie Inc., Novartis AG, Alcon Inc., Bausch Health Companies Inc., Bausch & Lomb Incorporated Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Johnson & Johnson Vision Care Inc., Lumenis Ltd., Staar Surgical Company, Glaukos Corporation, Sight Sciences Inc., Ocular Therapeutix Inc., Iridex Corporation, Ellex Medical Lasers Ltd., New World Medical Inc., MicroSurgical Technology Inc., Nova Eye Medical Limited, Asico LLC, Ziemer Ophthalmic Systems AG, Transcend Medical, iSTAR Medical SA, Ivantis Group Inc., Allergan, InnFocus Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/minimally-invasive-glaucoma-surgery-migs-devices-global-market-report

Which Region Offers The Most Opportunity For Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Expansion?

North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (MIGS) devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15863&type=smp

Browse Through More Reports Similar to the Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market 2025, By The Business Research Company

Minimally Invasive Surgery Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/minimally-invasive-surgery-global-market-report

Minimally Invasive Surgical Instruments Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/minimally-invasive-surgical-instruments-global-market-report

Minimally Invasive And Non Invasive Product And Service Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/minimally-invasive-and-non-invasive-product-and-service-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795